A Phase 2 interventional study of ASP1941 and Placebo in Diabetes Mellitus, Type 2, sponsored by Astellas Pharma Inc. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-11-14.
Sponsored by Astellas Pharma Inc · Phase 2, Interventional, and Treatment
This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus
Trial includes a two week washout period before entering the treatment period for subjects on oral anti-diabetic medication.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 61 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Astellas Pharma Inc is the lead sponsor of 512 studies on the registry; 4 are open to participants now.
Of its 27 completed or terminated interventional studies of FDA-regulated products, 19 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Oral
Drug: ASP1941
Oral
Drug: ASP1941
Oral
Drug: ASP1941
Oral
Drug: ASP1941
Oral
Drug: Placebo
Oral
Oral
Evaluation of safety through clinical safety labs and adverse events
Time frame: 6 Weeks
Evaluation of routine PK and PD parameters
Time frame: 6 Weeks
Plan to share: No — Access to anonymized individual participant level data will not be provided for this trial. Further details on Astellas' data sharing policy can be found at https://www.clinicaltrials.astellas.com/transparency/.
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Astellas Pharma Inc